Status:

UNKNOWN

Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis

Lead Sponsor:

Evangelisches Krankenhaus Düsseldorf

Conditions:

Pancreatitis, Calcific

Pancreatitis, Chronic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Investigation of the efficacy and safety of digital catheter-based pancreatoscopy (DCP) for the Treatment of symptomatic Stones of the pancreatic duct in selected patients with chronic calcifying panc...

Detailed Description

Background Endoscopic treatment of patients with chronic calcifying pancreatitis (CCP) is still challenging and controversially discussed. The goal is symptom control and relief of pain, which can be ...

Eligibility Criteria

Inclusion

  • Eligible patients are adults (≥ 18 years of age) with a signed informed consent with:
  • symptomatic chronic pancreatitis (recurrent pain attacks, history of pain for at least 3 months), and
  • ≤3 radiopaque stones ≥5mm obstructing the MPD in the pancreatic head and/or corpus.

Exclusion

  • \- Health status ASA 4
  • Pregnancy
  • Coagulopathy (INR≥2.0, Platelets \< 70/nl)
  • Taking anti-platelet agents or anticoagulants (other than aspirin) within last 7 days
  • Any medical contraindication to ERCP, deep sedation or general anesthesia
  • History of chronic symptomatic pancreatitis of more than 3-4 years\[9\]
  • History of daily use of opioids except Tramadol for more than 6 months in the last 2 years
  • Episode of biliary obstruction in the previous 2 months (defined as jaundice or bilirubin levels \>=2,5mg/dl or CBD stent
  • Auto-Immune Pancreatitis or IgG4 associated pancreatitis
  • Altered GI anatomy, previous failures of endoscopic approach to the papilla
  • Abdominal pain not attributable to CP
  • Any suspicion of pancreatic cancer
  • Current symptomatic WON
  • More than one ductal stricture in the pancreatic head or body
  • Previous ESWL pancreatic stones
  • Age \<18

Key Trial Info

Start Date :

May 31 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT04131010

Start Date

May 31 2019

End Date

December 1 2022

Last Update

October 29 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Evangelisches Krankenhaus Düsseldorf

Düsseldorf, North Rhine-Westphalia, Germany, 40217